Author:
Pauli Bendicht U.,Gruber Achim D.,Weinstein Ronald S.
Publisher
Springer Berlin Heidelberg
Reference60 articles.
1. Altman NH, Goodman DG (1979) Neoplastic diseases. In: Baker HJ, Lindsey JR, Weisbroth SH (eds) The laboratory rat, vol 1. Biology and diseases. Academic. NewYork, pp 333–376
2. Asamoto M, Cohen SM (1994) Prohibitin gene is overexpressed but not mutated in rat bladder and cell lines. Cancer Lett 83:201–207
3. Asamoto M, Mann AM, Cohen SM (1994a) P53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. Carcinogenesis 15:455–458
4. Asamoto M, Mann AM, Macatee TL. Cohen SM (1994b) Mutations and expression of the gene in rat bladder carcinomas and cell lines. Mol Carcinog 9:236–244
5. Becci PJ, Thompson HJ, Grubbs CJ. Squire RA. Brown CC, Sporn MB, Moon RC (1979) A quantitative dosing schedule for the induction of TCCs in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl) nitrosamines. J Natl Cancer lnst 62:187–191